Ketamine (Ketaset)

Ketamine, available under brand names including Ketaset, is a dissociative anesthetic that has been a cornerstone of veterinary anesthesia for decades. This medication produces a unique state of anesthesia characterized by profound analgesia, sedation, and amnesia while maintaining certain protective reflexes that are lost with other anesthetic agents. Ketamine belongs to the phencyclidine derivative class of drugs and works through mechanisms distinctly different from other injectable anesthetics, making it a valuable tool in the veterinary anesthesiologist's armamentarium. In feline medicine specifically, ketamine has found widespread application due to its effectiveness in cats and the species' generally favorable response to the drug.

The mechanism of action of ketamine involves antagonism of N-methyl-D-aspartate (NMDA) receptors in the central nervous system, which distinguishes it from other anesthetic agents that primarily work through GABA modulation. By blocking NMDA receptors, ketamine interrupts the transmission of pain signals and produces the characteristic dissociative state where the patient appears disconnected from their environment. This dissociative anesthesia maintains many brainstem reflexes, including swallowing and corneal reflexes, though these should not be relied upon for airway protection. Ketamine also interacts with opioid receptors and other neural pathways, contributing to its analgesic properties. The onset of action following intramuscular injection is typically three to five minutes, with duration of anesthesia lasting approximately twenty to forty minutes.

Ketamine is available as a clear, colorless injectable solution, most commonly at a concentration of one hundred milligrams per milliliter. The drug can be administered via multiple routes including intramuscular, intravenous, and subcutaneous injection, though intramuscular administration is most common in feline practice. One of ketamine's practical advantages is that effective anesthesia can be achieved via intramuscular injection, making it valuable for situations where intravenous access is difficult or dangerous to establish, such as with fractious cats. The drug is highly water-soluble and stable in solution, with a long shelf life when stored appropriately. Ketamine is almost always used in combination with other drugs in modern veterinary practice to improve the quality of anesthesia and recovery.

While ketamine has a long track record of use in veterinary medicine, it requires careful patient selection and appropriate combination with other agents to optimize outcomes. Cats generally tolerate ketamine well, and it has traditionally been considered a particularly suitable anesthetic for this species. However, ketamine used alone produces muscle rigidity, poor muscle relaxation, and can cause rough or prolonged recoveries. Modern protocols therefore combine ketamine with sedatives, muscle relaxants, and analgesics to create balanced anesthesia. The drug's Schedule III controlled substance status reflects its potential for abuse and necessitates careful inventory control and documentation in veterinary facilities. Veterinary supervision is essential, as proper patient monitoring and support must be available whenever ketamine is administered.

The primary indication for ketamine in feline patients is the induction of dissociative anesthesia for surgical and diagnostic procedures requiring immobilization and analgesia. Ketamine produces a cataleptic state characterized by profound analgesia and sedation while maintaining muscle tone and certain reflexes. This makes it suitable for a wide range of procedures from minor interventions to more significant surgical operations when combined with appropriate additional agents. The drug's reliability and versatility have made it one of the most commonly used injectable anesthetics in veterinary practice worldwide, with particularly extensive experience in feline patients.

Chemical restraint represents another major application for ketamine in veterinary medicine. Cats that cannot be safely handled for examination, sample collection, or minor procedures can be safely immobilized with appropriate ketamine combinations. This application is particularly valuable for feral cat management, including trap-neuter-return programs where large numbers of cats require rapid, reliable anesthesia for surgical sterilization. The ability to administer ketamine intramuscularly without prior intravenous access makes it ideal for these situations. Animal shelter medicine has similarly embraced ketamine protocols for their efficiency and effectiveness in high-volume spay-neuter operations.

Ketamine's analgesic properties make it valuable beyond pure anesthesia applications. The drug provides significant somatic analgesia, particularly effective for superficial and musculoskeletal pain. This analgesic effect is mediated through NMDA receptor antagonism, which also provides benefits for preventing central sensitization and wind-up phenomena associated with chronic or severe pain. Sub-anesthetic doses of ketamine are sometimes used as adjunctive analgesics in multimodal pain management protocols, particularly for patients with severe or chronic pain conditions. This analgesic application has gained increased attention as understanding of ketamine's effects on pain processing has evolved.

Emergency medicine applications for ketamine include rapid sedation of severely injured or critically ill cats requiring immediate intervention. The drug's maintenance of cardiovascular function and respiratory drive at appropriate doses can be advantageous in trauma patients or those with hemodynamic instability. Ketamine can facilitate emergency airway management, wound assessment and treatment, or stabilization procedures. The drug's bronchodilatory effects may provide benefit in cats with respiratory compromise from asthma or other bronchoconstriction. However, the cardiovascular stimulation associated with ketamine may be contraindicated in certain cardiac conditions.

Veterinary selection of ketamine over other injectable anesthetics depends on multiple factors including the specific clinical situation, required duration of effect, available monitoring capabilities, and patient characteristics. Ketamine's ability to maintain cardiovascular function makes it suitable for patients where other anesthetics might produce dangerous hypotension. The drug's effectiveness via intramuscular administration is valuable when intravenous access is impractical. Cost considerations also favor ketamine in many situations, as it remains less expensive than some newer anesthetic agents. However, the quality of recovery and need for combination protocols mean that ketamine is not always the optimal choice, and veterinarians weigh these factors for each individual patient.

Ketamine administration is exclusively performed by veterinary professionals in appropriate clinical settings, with the specific protocol determined by the patient's needs, the procedure planned, and concurrent medications used. Cat owners do not administer ketamine at home, as this controlled substance requires proper handling, precise dosing, and continuous patient monitoring during its effects. The veterinary team considers numerous factors when designing ketamine-based anesthetic protocols, and understanding these principles helps cat owners appreciate the expertise involved in safely anesthetizing their pets.

Intramuscular injection is the most common route of ketamine administration in feline practice, particularly for initial chemical restraint of fractious or difficult-to-handle cats. Typical intramuscular doses for anesthesia induction range from five to fifteen milligrams per kilogram when ketamine is used in combination with other agents. The wide dose range reflects the significant influence of concurrent medications on ketamine requirements. When ketamine is combined with alpha-2 agonists such as dexmedetomidine or medetomidine, substantially lower ketamine doses are needed compared to combinations with benzodiazepines or acepromazine. The veterinary team selects specific combinations based on the patient's health status and procedure requirements.

Intravenous administration of ketamine produces more rapid onset of effect compared to intramuscular injection, with anesthesia typically occurring within one to two minutes. Intravenous doses are generally lower than intramuscular doses, often in the range of two to ten milligrams per kilogram depending on concurrent medications. This route is commonly used when intravenous access has already been established or when rapid onset is required. Some protocols use intramuscular ketamine combinations for initial immobilization, followed by intravenous supplementation as needed for procedure extension. Intravenous ketamine can also be administered as a continuous rate infusion for anesthetic maintenance or analgesic purposes.

The combination of ketamine with other agents is standard practice in modern veterinary anesthesia to optimize the quality of anesthesia and recovery. Benzodiazepines such as midazolam or diazepam provide muscle relaxation that counters ketamine's tendency to cause muscle rigidity, while also enhancing sedation. Alpha-2 agonists including dexmedetomidine provide excellent sedation, analgesia, and muscle relaxation, allowing reduced ketamine doses. These combinations typically produce smoother induction, better surgical conditions, and improved recovery quality compared to ketamine alone. The choice of combination depends on the patient's health status, with alpha-2 agonists generally avoided in patients with cardiovascular disease or other contraindications.

Treatment duration with ketamine depends on the specific protocol used and the procedure being performed. A single intramuscular injection of a ketamine combination typically provides fifteen to forty minutes of surgical anesthesia, with additional doses extending this duration as needed. Recovery time varies considerably depending on the total dose administered and the specific drug combination used. Alpha-2 agonist combinations often allow for reversal of the sedative component, which can substantially shorten recovery time. The veterinary team monitors patients throughout recovery, which may take one to several hours depending on the protocol.

Accurate weight determination is essential for safe ketamine dosing, as with all anesthetic agents. The veterinary team weighs patients before procedures and calculates doses precisely based on current body weight. Dose adjustments are made for patient factors including age, health status, and concurrent medications. Debilitated, geriatric, or very young patients typically require reduced doses due to altered drug distribution and metabolism. The goal is to use the minimum effective dose to achieve the required level of anesthesia while minimizing the risk of adverse effects and prolonged recovery.

Ketamine produces characteristic effects that distinguish it from other anesthetic agents, some of which may be considered side effects depending on the clinical context. Understanding these effects helps veterinary teams anticipate and manage them appropriately. When used in appropriate combinations with proper monitoring, ketamine is generally safe and effective, though certain adverse effects can occur and should be recognized promptly.

The most notable characteristic of ketamine anesthesia is the maintenance of muscle tone and certain reflexes that are abolished by other anesthetics. While maintenance of protective reflexes may seem advantageous, the presence of eye reflexes can complicate assessment of anesthetic depth. Cats under ketamine anesthesia typically have open eyes with intact corneal reflexes, requiring application of ophthalmic lubricant to prevent corneal drying and damage. The muscle rigidity or increased tone associated with ketamine can interfere with certain procedures and is one reason why muscle relaxant combinations are standard practice. Salivation is commonly increased with ketamine, particularly when administered alone, and anticholinergic premedication may be used to reduce this effect.

Cardiovascular effects of ketamine differ markedly from other anesthetic agents. Ketamine typically produces cardiovascular stimulation, with increases in heart rate, blood pressure, and cardiac output mediated through sympathetic nervous system activation. While this effect can be advantageous in maintaining hemodynamic stability during anesthesia, it may be detrimental in patients with certain cardiac conditions. Cats with hypertrophic cardiomyopathy or hyperthyroidism may experience dangerous increases in cardiac workload under ketamine anesthesia. The cardiovascular stimulant effects may also increase bleeding during surgery. Combination with alpha-2 agonists partially counteracts these cardiovascular effects, producing more balanced hemodynamic profiles.

Respiratory effects of ketamine are generally mild at clinically used doses, with maintenance of respiratory drive being one of the drug's advantages. However, apneustic breathing patterns characterized by prolonged inspiratory phases may occur. Ketamine has bronchodilatory properties that can be beneficial in cats with asthma or other bronchoconstrictive conditions. At higher doses or with rapid intravenous administration, respiratory depression can occur and may require ventilatory support. The maintenance of airway reflexes should not lead to complacency regarding airway management, as aspiration remains possible and supplemental oxygen is recommended during ketamine anesthesia.

Recovery from ketamine anesthesia can be prolonged and rough compared to some other anesthetic agents, particularly when ketamine is used alone or in inappropriate combinations. Cats may exhibit emergence phenomena including vocalization, hyperexcitability, disorientation, and exaggerated responses to stimuli. These effects are related to the drug's mechanism of action and the gradual return of normal neural processing. Recovery in a quiet, dimly lit environment helps minimize emergence reactions. Appropriate combination protocols using benzodiazepines or alpha-2 agonists substantially improve recovery quality. The ability to reverse alpha-2 agonists can accelerate recovery while maintaining quality when rapid return to function is desired.

Ketamine is contraindicated in cats with known hypersensitivity to the drug, though true allergic reactions are rare. More commonly, contraindications relate to specific medical conditions where ketamine's pharmacological effects would be detrimental. Understanding these contraindications helps ensure appropriate patient selection and alternative anesthetic planning when ketamine use is not advisable. Complete disclosure of a cat's medical history to the veterinary team is essential for safe anesthetic planning.

Cardiovascular disease represents an important consideration when ketamine use is contemplated. The drug's stimulation of the sympathetic nervous system increases heart rate, blood pressure, and myocardial oxygen demand. In cats with hypertrophic cardiomyopathy, the most common feline cardiac disease, these effects can precipitate dangerous arrhythmias, cardiac decompensation, or even sudden death. Cats with hyperthyroidism, which often coexists with cardiac changes, may similarly be poor candidates for ketamine anesthesia. Significant hypertension from any cause may be exacerbated by ketamine's cardiovascular stimulant effects. Thorough cardiac evaluation, potentially including echocardiography, is advisable before anesthetizing cats with known or suspected heart disease.

Conditions involving increased intracranial or intraocular pressure are traditionally considered contraindications to ketamine use. The drug can increase cerebral blood flow and may elevate intracranial pressure, which could be dangerous in cats with head trauma, intracranial masses, or hydrocephalus. Similarly, ketamine may increase intraocular pressure, making it unsuitable for cats with glaucoma or for procedures requiring normal intraocular pressure. While some recent evidence suggests these effects may be less significant than historically believed, particularly when ketamine is combined with other agents, alternative anesthetics may be preferred when these conditions are present.

Renal and hepatic dysfunction require careful consideration when planning ketamine anesthesia. Ketamine undergoes hepatic metabolism, and cats with significant liver disease may have prolonged drug effects and recovery. The drug is partially excreted unchanged by the kidneys, and renal insufficiency can similarly extend its duration of action. Given the high prevalence of chronic kidney disease in older cats, renal function assessment is an important component of pre-anesthetic evaluation. While ketamine can be used in patients with mild to moderate organ dysfunction with appropriate dose adjustments and monitoring, severe hepatic or renal failure may necessitate alternative anesthetic approaches. Complete blood work including liver and kidney parameters helps guide these decisions.

Ketamine is almost always used in combination with other drugs in modern veterinary practice, making understanding of drug interactions essential for safe protocol design. These interactions may be intentional and beneficial, improving the quality of anesthesia, or potentially harmful if not properly anticipated and managed. The veterinary team carefully considers all concurrent medications when planning ketamine-based anesthetic protocols.

Alpha-2 adrenergic agonists including dexmedetomidine and medetomidine produce profound synergistic effects when combined with ketamine, dramatically reducing the dose of each drug needed while improving overall anesthetic quality. This combination is one of the most commonly used anesthetic protocols in feline practice, providing excellent sedation, analgesia, and muscle relaxation. The cardiovascular effects of the two drug classes partially counteract each other, with alpha-2 agonists producing bradycardia and vasoconstriction while ketamine causes tachycardia and increased cardiac output. The availability of reversal agents for alpha-2 agonists allows rapid recovery when this component is antagonized. However, this combination requires careful patient selection, as alpha-2 agonists have significant contraindications of their own.

Benzodiazepines including midazolam and diazepam are frequently combined with ketamine to provide muscle relaxation and enhanced sedation. This combination improves surgical conditions by reducing the muscle rigidity associated with ketamine alone and generally produces smoother recoveries with fewer emergence phenomena. Benzodiazepines have minimal cardiovascular effects, making this combination suitable for a broader range of patients than alpha-2 agonist combinations. However, benzodiazepine-ketamine combinations typically require higher ketamine doses than alpha-2 combinations and may not provide equivalent analgesia. Reversal agents for benzodiazepines exist but are less commonly used than alpha-2 antagonists.

Central nervous system depressants generally enhance ketamine's effects and may require dose adjustments. Opioid analgesics are commonly included in ketamine protocols to provide analgesia, as ketamine's analgesic effects, while significant, may not be sufficient for highly painful procedures. Phenothiazine tranquilizers such as acepromazine can be combined with ketamine, though this combination is less commonly used in modern practice due to the superior performance of other combinations. Any cat receiving other sedatives, anticonvulsants, or central nervous system active drugs may show enhanced or prolonged effects from ketamine. Complete medication history is essential for appropriate protocol planning.

Informed disclosure of all medications, supplements, and recent treatments helps the veterinary team plan the safest possible anesthetic protocol. Certain supplements may affect cardiovascular function or drug metabolism in ways that influence ketamine effects. Previous recent anesthesia can affect drug requirements and recovery. Cats receiving chronic medications for various conditions may require protocol modifications. Even over-the-counter products or supplements given without veterinary guidance should be disclosed, as these may contain active ingredients with potential for interaction.

Ketamine administration requires appropriate facilities, monitoring equipment, and trained personnel prepared to manage potential complications. As a controlled substance, ketamine is subject to specific regulatory requirements regarding storage, documentation, and handling that veterinary facilities must follow. These precautions exist to ensure patient safety, prevent drug diversion, and maintain the standards of veterinary care. Cat owners should ensure their veterinary facility follows current monitoring and safety standards.

Patient monitoring during ketamine anesthesia presents unique challenges due to the drug's distinctive effects on reflexes and vital signs. Standard monitoring parameters including heart rate, respiratory rate, oxygen saturation, and temperature remain important, but interpretation differs from other anesthetic agents. The presence of eye reflexes and muscle tone that would indicate light anesthesia with other drugs is normal with ketamine. Experienced veterinary teams familiar with ketamine anesthesia monitor appropriate parameters and recognize the signs of adequate versus inadequate anesthetic depth specific to this agent. Body temperature regulation is impaired during anesthesia, and active warming is typically necessary to prevent hypothermia.

Recovery from ketamine anesthesia requires a safe, controlled environment where cats can recover without risk of injury. The prolonged recovery period and potential for emergence excitement mean that recovering patients should be confined in padded enclosures away from stairs, elevated surfaces, or other hazards. A quiet, dimly lit environment helps minimize sensory stimulation that can trigger emergence reactions. Veterinary staff monitor recovering patients closely and intervene with additional sedation if emergence phenomena are severe. Cat owners should understand that their pet may appear disoriented or uncoordinated for several hours following ketamine anesthesia and should follow all post-anesthetic instructions carefully.

Specific patient populations require additional precautions when ketamine is used. Geriatric cats often have decreased organ function affecting drug metabolism and excretion, typically requiring reduced doses and allowing for longer recovery times. Young kittens may have immature hepatic enzyme systems and also require careful dose adjustment. Pregnant cats generally should avoid anesthesia when possible, though ketamine can be used when necessary with appropriate consideration of fetal effects. Cats with respiratory disease may benefit from ketamine's bronchodilatory effects but require careful monitoring for apneustic breathing patterns.

Multi-cat households present particular considerations when one cat undergoes ketamine anesthesia. The recovering cat should be separated from other pets until fully recovered to prevent injury from inappropriate interactions or falls. Other cats may behave differently toward the recovering cat due to altered scent from the veterinary visit and residual drug effects. Gradual reintroduction after full recovery is advisable if any social tension exists between household cats. The recovering cat should have easy access to food, water, and litter without needing to navigate stairs or jump to elevated locations until fully coordinated.

Ketamine requires storage according to both manufacturer specifications and controlled substance regulations applicable to Schedule III drugs. The medication should be stored at controlled room temperature, typically between fifteen and thirty degrees Celsius (59 to 86 degrees Fahrenheit), protected from light. Freezing should be avoided as this may affect drug stability. As a controlled substance, ketamine must be stored in a securely locked cabinet or safe with access limited to authorized personnel. Veterinary facilities maintain specific protocols for controlled substance security that comply with federal, state, and local regulations.

Controlled substance documentation requirements mandate careful record-keeping for all ketamine transactions including acquisition, use, waste, and disposal. Veterinary facilities maintain logs recording every instance of ketamine removal from secure storage, the amount used, the patient receiving the drug, and any waste generated. These records are subject to regulatory inspection and must balance accurately with physical inventory. The documentation requirements exist to prevent drug diversion and ensure appropriate use of controlled substances. Multiple staff members may be involved in verification processes for controlled substance handling.

Ketamine solution is generally stable and has a relatively long shelf life when stored properly. The clear, colorless solution should be inspected before each use to verify absence of particulate matter, cloudiness, or discoloration. Any vials showing visible changes should not be used even if within the labeled expiration period. Multi-dose vials should be handled using aseptic technique to prevent contamination. Most facilities use ketamine from multi-dose vials over extended periods given the drug's stability, though institutional protocols regarding multi-dose vial use vary. Proper dating and rotation of stock ensures that older inventory is used before newer supplies.

Disposal of unused ketamine and related waste follows both pharmaceutical waste guidelines and controlled substance destruction requirements. Waste ketamine from partial vials or drawn-up but unused portions must be documented and disposed of according to DEA regulations, typically requiring witnessed destruction or use of approved disposal systems. Sharps including needles and syringes used for ketamine administration are disposed of in approved sharps containers. Empty vials may need to be defaced or rendered unusable before disposal depending on local requirements. These disposal procedures prevent environmental contamination and eliminate the possibility of drug diversion from waste streams.

Ketamine has been used safely in virtually all domestic cat breeds, with individual patient factors generally playing a more significant role than breed in determining drug response. However, veterinary anesthetists maintain awareness of breed-associated disease predispositions that may influence the safety of ketamine anesthesia. A thorough pre-anesthetic evaluation considers breed alongside other patient characteristics including age, weight, health status, and concurrent medications.

Breeds with known predisposition to hypertrophic cardiomyopathy deserve particular consideration when ketamine anesthesia is planned. Maine Coons, Ragdolls, British Shorthairs, and several other breeds have elevated prevalence of this cardiac condition, which may be a relative or absolute contraindication to ketamine depending on severity. Ketamine's cardiovascular stimulant effects can be particularly dangerous in cats with undiagnosed or poorly controlled heart disease. Pre-anesthetic cardiac evaluation including auscultation and potentially echocardiography is advisable for breeds with known cardiac predispositions, particularly before elective procedures. Alternative anesthetic protocols may be recommended if significant cardiac disease is identified.

Brachycephalic breeds including Persians, Himalayans, and Exotic Shorthairs present airway management considerations with any anesthetic protocol, including ketamine. The maintenance of muscle tone and reflexes with ketamine may actually provide some advantage in these breeds by supporting airway patency during recovery. However, the prolonged recovery associated with ketamine could extend the period of airway vulnerability. Careful monitoring throughout recovery is essential for brachycephalic patients regardless of the anesthetic protocol used. The veterinary team may select specific ketamine combinations or alternative protocols based on the individual patient's airway anatomy and risk assessment.

Size variation among cat breeds influences practical aspects of ketamine dosing and administration. Large breeds such as Maine Coons may require larger absolute doses but still require accurate per-kilogram dosing to avoid overdose. Very small breeds present challenges in measuring precise doses from concentrated ketamine solutions, potentially requiring dilution for accurate administration. Accurate weight measurement immediately before anesthesia is essential regardless of breed or size. The veterinary team selects appropriate syringes and measurement techniques to ensure dosing accuracy across the range of feline patient sizes encountered in practice.

Several other dissociative anesthetic agents exist, though ketamine remains the primary drug in this class used in veterinary medicine. Tiletamine, available in combination with the benzodiazepine zolazepam as Telazol, provides similar dissociative anesthesia with potentially longer duration of action. Phencyclidine, the parent compound of the dissociative class, is not used in veterinary practice due to its prolonged effects and regulatory status. Research continues into other NMDA antagonists and dissociative agents, but ketamine's long track record and well-characterized effects maintain its position as the most commonly used dissociative anesthetic.

Within the broader category of injectable anesthetics, several alternatives to ketamine exist with different mechanisms and characteristics. Propofol provides rapid, smooth induction with quick recovery but requires intravenous administration and has no inherent analgesic properties. Alfaxalone offers similar advantages to propofol with potentially better cardiovascular stability. These agents may be preferred over ketamine when smooth, rapid recovery is paramount or when ketamine's specific effects are contraindicated. The choice between injectable anesthetics depends on patient factors, procedure requirements, available monitoring capabilities, and veterinary preference.

Inhalant anesthetics including isoflurane and sevoflurane represent alternative approaches for anesthetic maintenance and are commonly used following injectable induction. Some protocols use ketamine combinations for induction followed by transition to inhalant maintenance for longer procedures. This approach can provide the benefits of ketamine's intramuscular induction capability while avoiding the prolonged recovery associated with high total ketamine doses. Pure inhalant protocols using mask or chamber induction represent alternatives to injectable induction, though these approaches are often more stressful for cats and are less commonly used in conscious animals.

Complementary medications used alongside ketamine optimize overall anesthetic quality and address its limitations. Alpha-2 agonists or benzodiazepines provide muscle relaxation and improved recovery quality. Opioid analgesics supplement ketamine's analgesia for painful procedures. Anticholinergics may reduce salivation. The specific combination protocol is tailored to each patient's needs and the planned procedure. Veterinary anesthetists draw on extensive experience with various drug combinations to create individualized protocols that maximize safety and effectiveness while minimizing adverse effects.